OLPX vs. NUS, HELE, NTCOY, IPAR, ODD, EPC, WALD, YSG, SHOT, and UG
Should you be buying Olaplex stock or one of its competitors? The main competitors of Olaplex include Nu Skin Enterprises (NUS), Helen of Troy (HELE), Natura &Co (NTCOY), Inter Parfums (IPAR), Oddity Tech (ODD), Edgewell Personal Care (EPC), Waldencast (WALD), Yatsen (YSG), Safety Shot (SHOT), and United-Guardian (UG).
Olaplex (NASDAQ:OLPX) and Nu Skin Enterprises (NYSE:NUS) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, community ranking, media sentiment, valuation, institutional ownership, analyst recommendations, risk and dividends.
In the previous week, Olaplex had 1 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 6 mentions for Olaplex and 5 mentions for Nu Skin Enterprises. Olaplex's average media sentiment score of 0.94 beat Nu Skin Enterprises' score of 0.87 indicating that Olaplex is being referred to more favorably in the media.
Nu Skin Enterprises received 481 more outperform votes than Olaplex when rated by MarketBeat users. Likewise, 64.23% of users gave Nu Skin Enterprises an outperform vote while only 34.12% of users gave Olaplex an outperform vote.
87.4% of Olaplex shares are held by institutional investors. Comparatively, 82.8% of Nu Skin Enterprises shares are held by institutional investors. 4.2% of Olaplex shares are held by insiders. Comparatively, 1.7% of Nu Skin Enterprises shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Olaplex has a beta of 2.34, suggesting that its share price is 134% more volatile than the S&P 500. Comparatively, Nu Skin Enterprises has a beta of 1.13, suggesting that its share price is 13% more volatile than the S&P 500.
Olaplex has higher earnings, but lower revenue than Nu Skin Enterprises. Nu Skin Enterprises is trading at a lower price-to-earnings ratio than Olaplex, indicating that it is currently the more affordable of the two stocks.
Olaplex has a net margin of 10.91% compared to Nu Skin Enterprises' net margin of -0.17%. Olaplex's return on equity of 11.61% beat Nu Skin Enterprises' return on equity.
Olaplex currently has a consensus target price of $2.51, indicating a potential upside of 65.30%. Nu Skin Enterprises has a consensus target price of $20.83, indicating a potential upside of 59.76%. Given Olaplex's stronger consensus rating and higher possible upside, equities analysts clearly believe Olaplex is more favorable than Nu Skin Enterprises.
Summary
Olaplex beats Nu Skin Enterprises on 15 of the 18 factors compared between the two stocks.
Get Olaplex News Delivered to You Automatically
Sign up to receive the latest news and ratings for OLPX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding OLPX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
